Wyss Zurich News

Find out about the latest news and what’s happening at Wyss Zurich! Learn more about the status of our current projects and stay informed about our alumni projects and related startups.

Featured News

Wyss Zurich celebrated its 10th anniversary at the Annual Event on November 3rd 2025. Over 300 guests gathered at the Kongresshaus Zurich to celebrate 10 years of impact by the Wyss Zurich Translational Center.

All News

NovaGo Therapeutics AG named finalist for prestigious Strüngmann Award 2025

Swiss Biotech Startups dominate the prestigious Strüngmann Award 2025 – NovaGo Therapeutics AG among the three finalists

NovaGo Therapeutics AG announces start of the Phase Ib SPROUT clinical trial

NovaGo Therapeutics AG has kickstarted the Phase Ib SPROUT clinical trial. The first patient has now been dosed with the NG004 drug to evaluate the safety and pharmacology the antibody therapy on patients with acute spinal cord injury.

Groundbreaking results observed from NovaGo Therapeutics AG’s Phase IIb NISCI trial

The antibody therapy, NG101 showed evidence of improvement in motor function and functional independence in patients with motor-incomplete Spinal Cord Injury (SCI).

Nogo Inhibition in Spinal Cord Injury – NISCI trial completed patient enrollment

The Wyss Zurich CeNeReg team and the EU Horizon 2020 NISCI clinical team are happy to announce that the NISCI – Nogo Inhibition in Spinal Cord Injury – Phase II randomized controlled clinical trial has completed the enrollment of its required 127 acutely spinal cord injured patients.

WELT – Getting out of the wheelchair

In most cases, paraplegia is not curable. After nearly thirty years of research, a neurobiologist is now testing a drug designed to regrow nerve fibers in the spinal cord.

Sign up for our newsletter!

For newsletter distribution, your email address will be processed by a GDPR-certified service provider. Further information can be found in our privacy policy.

Got a Breakthrough Idea? Let’s build the future together.

At Wyss Zurich, we helpt entrepreneurial teams from ETH Zurich and University of Zurich transform their projects in a real-world solution. Contact us to learn more about our application process.